Acquisition and Stockholders' Equity (Deficit) (Details) (USD $)	0 Months Ended	1 Months Ended	12 Months Ended								0 Months Ended			0 Months Ended
	Nov. 30, 2011	Dec. 31, 2005	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008	Jan. 15, 2013	Nov. 20, 2009	Jul. 14, 2008 Pawfect employee	Jul. 21, 2008 Pawfect	Jul. 20, 2008 Pawfect	Jul. 14, 2008 Pawfect Principal stockholder	Jul. 14, 2008 Pawfect Callisto
Percentage of common stock acquired in Synergy-DE											100.00%
Exchange of unregistered common stock (in shares)											22,732,380
Number of shares received in an exchange transaction (in shares)															22,295,000
Percentage of Pawfect's outstanding common stock issued in exchange transaction (as a percent)											70.00%				68.00%
Stock split ratio	0.5										37.845338
Cancellation of common stock (in shares)														74,990,604
Number of unregistered shares owned														75,690,603
Private placement of unregistered common stock		$ 18,000	$ 94,734,000	$ 55,862,000			$ 15,970,000	$ 3,025,000			$ 3,000,000
Private placement of unregistered common stock (in shares)											2,500,000
Fees and expenses related to private placements			5,623,000	3,774,000	2,148,000	468,000	260,000	73,000			73,088
Net proceeds from private placement											2,926,912
Common stock, par value (in dollars per share)			$ 0.0001	$ 0.0001								$ 0.0001	$ 0.001
Common stock price (in dollars per share)											$ 1.20
Number of full time employees retained											4
Goodwill											0
Assets
Cash											194,674
Total assets acquired											194,674
Liabilities
Accounts payable and other liabilities											(722,320)
Due to Callisto											(350,000)
Total liabilities assumed											(1,072,320)
Net liabilities assumed in excess of assets acquired											(877,646)
Fair value of shares issued to Synergy-DE shareholders											(27,278,856)
Total consideration paid by Pawfect to acquire Synergy-DE											$ (28,156,502)
Authorized number of common shares			200,000,000	100,000,000					200,000,000	100,000,000		75,000,000	25,000,000
Authorized number of preferred shares			20,000,000	20,000,000								20,000,000